How many human screwworm cases will be reported in the United States in 2026?
$0.00
1
6
How many human screwworm cases will be reported in the United States in 2026?
$0.00
1
6
AI Analysis
Trader mode: Actionable analysis for identifying opportunities and edge
About This Event
2026 If the total number of New World screwworm infestation cases reported in the United States during 2026 is above X then the market resolves to Yes. Cases are determined at 10:00 AM ET on the Expiration Date, January 8. Cases that actually occur between the end of the specified time period and Expiration do not count, but newly reported cases during this window do count if they are backdated to 2026. See the full rules for how Source Agencies are prioritized. This market refers exclusively t
What Prediction Markets Are Forecasting
Traders on Kalshi currently give about a 27% chance that at least one New World screwworm case will be reported in the United States during 2026. That's roughly a 1 in 4 shot, which means the market leans toward "no cases," but not with overwhelming confidence. If this were a weather forecast, you'd still pack an umbrella.
The market is essentially asking: will a flesh-eating parasite that was eradicated from the U.S. in 1966 make a comeback in 2026? The odds suggest traders think it's possible but not probable. For context, a 27% probability is similar to the chance of flipping a coin twice and getting heads both times. Not something you'd bet your house on, but hardly a long shot either.
Why the Market Sees It This Way
The New World screwworm is a fly larva that infests warm-blooded animals, including humans, feeding on living tissue. It was officially eradicated from the U.S. through a decades-long sterile insect technique program, where millions of sterilized male flies were released to disrupt breeding. That program remains one of the great success stories of veterinary entomology.
But the threat hasn't disappeared. The parasite is still endemic in parts of South America and the Caribbean. In 2016, an outbreak in the Florida Keys infected deer and led to a brief agricultural emergency. More recently, in 2023, Costa Rica declared a national emergency over screwworm outbreaks in livestock. Central America has seen a steady northward creep of cases, partly linked to climate change and animal movement across borders.
The market likely sees the U.S. as having strong surveillance and rapid response systems, which historically have contained incursions quickly. But the parasite's persistence in nearby regions, combined with increased global travel and animal imports, keeps the risk real. Traders may also be factoring in that detection capabilities have improved, meaning even a single imported case would likely get reported.
Key Dates and Events to Watch
The market resolves on January 8, 2027, but the real signals will come throughout 2026. Watch for USDA animal health alerts, particularly regarding livestock imports from Central America or the Caribbean. Any confirmed case in Mexico or along the U.S.-Mexico border would likely shift these odds upward quickly. Seasonal patterns matter too: screwworm activity peaks in warmer months, so late summer and early fall are the highest-risk windows. If no cases emerge by October, the odds of a clean year will probably climb.
How Reliable Are These Predictions?
Prediction markets have a decent track record with binary events like this, especially when the question is clear and information flows regularly. But this market has a wrinkle: the actual number of human cases in a year is extremely small, often zero. When the base rate is that low, even good markets can struggle. The 27% figure reflects genuine uncertainty, not just noise. If the market were at 2%, you could feel confident. At 50%, you'd be worried. At 27%, you're somewhere in between, which is probably where you should be.
Current Market Outlook
Kalshi traders give only a 27% chance that at least one human New World screwworm case will be reported in the United States during 2026. This is a low probability, meaning the market consensus expects zero cases. But 27% is not negligible. It is roughly the same odds as a 1-in-4 chance, which suggests traders see a real but unlikely risk.
The market resolves based on reports from the USDA, CDC, or state health departments. Cases must be backdated to 2026 even if reported after January 1, 2027. This gives the market a wide window for confirmation, which slightly favors the Yes side since delayed reporting is common with rare parasitic infections.
Key Factors Driving the Odds
New World screwworm is a parasitic fly that lays eggs in open wounds of warm-blooded animals, including humans. The larvae eat living tissue. The United States eradicated screwworm in the 1960s using sterile insect technique, but the pest remains endemic in Cuba, Haiti, and parts of South America.
The primary vector for human cases in the US is travel. Infected people or animals can carry larvae across borders. In 2024, a single human case was reported in California linked to a traveler returning from South America. That case broke a decades-long streak of zero human infections.
The 27% price reflects three realities. First, the US maintains active surveillance and sterile fly releases along the southern border. Second, livestock cases in Texas and Florida have been rising since 2023, suggesting the pest is expanding its range. Third, climate change may allow screwworm to survive winters in more US states, increasing the pool of potential animal hosts that could transmit to humans.
What Could Change These Odds
The key date is June 2026, when the USDA releases its annual screwworm surveillance report. If that report shows increased fly catches in Florida or Texas, expect the Yes probability to jump above 40%. A single confirmed animal case in a new state would also push odds higher.
The biggest risk to the current price is an outbreak in Puerto Rico or the US Virgin Islands. Those territories already have screwworm, and a spike there could spill into the mainland through air travel. Conversely, if the USDA announces expanded sterile fly releases or a new eradication campaign, the Yes price could drop below 15%.
The market is pricing in a low but real chance because the underlying risk is binary. Either the surveillance system catches every case, or it misses one. Given that the 2024 case was detected only because the patient sought treatment, the market is right to assign a non-trivial probability to a single undetected case slipping through.
AI-generated analysis based on market data. Not financial advice.
Overview
New World screwworm (NWS) is a parasitic fly species, Cochliomyia hominivorax, whose larvae infest the living tissue of warm-blooded animals, including humans. The adult female fly lays eggs on open wounds or mucous membranes; after hatching, the maggots feed on the host's flesh, causing severe tissue damage, secondary infections, and, if untreated, death. Historically, screwworm was endemic to the southern United States, but an aggressive eradication program using sterile insect technique (SIT) eliminated it from the U.S. by 1966. The pest remains established in parts of South America and the Caribbean, and periodic outbreaks occur when infested animals or people travel north. The prediction market question asks how many human cases will be reported in the United States in 2026, with the resolution threshold defined by the market's rules. This is a niche but epidemiologically significant metric because human cases are rare in the U.S. and typically signal a failure of animal surveillance and border controls. The market's outcome depends on official reports from agencies like the USDA and CDC, which prioritize case definitions and reporting timelines. Interest in this topic has grown since the 2024 re-emergence of screwworm in Mexico and a handful of human cases in the U.S. associated with imported animals. The question tests whether public health and agricultural systems can contain a pest that has both economic and medical consequences. For prediction market participants, the key drivers are USDA eradication program funding, border inspection efficacy, and climate conditions that affect fly range expansion. The market provides a concrete, measurable proxy for the health of the U.S. veterinary and public health surveillance infrastructure.
Historical Context
Screwworm has been a recurring problem in the United States since the early 19th century. The first documented human case of myiasis was reported in 1835 by Dr. John B. Smith in Texas, but the disease was not systematically tracked until the 1930s. In 1935, an outbreak in the southeastern U.S. caused an estimated $100 million in livestock losses (equivalent to over $2 billion today). The USDA launched a research program in 1937, and by 1954, scientists at the USDA-ARS laboratory in Kerrville, Texas, developed the sterile insect technique, which releases sterilized male flies to mate with wild females, reducing reproduction. A massive eradication campaign began in 1958, using aerial releases of sterile flies over the southeastern states. By 1966, the U.S. was declared screwworm-free, and a permanent barrier zone was established along the Mexico-U.S. border using sterile fly releases. Between 1966 and 2016, only three human cases were reported in the U.S., all linked to travel to endemic areas. In 2016, a major outbreak occurred in Florida's Key Deer population, with 133 animal cases and one human case confirmed in a Monroe County resident. The outbreak cost $15 million to contain and led to the temporary closure of the sterile fly production facility in Panama for repairs. The last human case in the U.S. before the current era was in 2018, when a traveler returning from Peru was diagnosed in New York. These historical patterns show that human cases are rare but can spike when animal surveillance fails, as seen in Florida in 2016.
Why It Matters
The number of human screwworm cases in the U.S. directly measures the effectiveness of border biosecurity and the national surveillance system. Each human case represents a sentinel event that likely indicates undetected animal cases, which can spread rapidly through livestock herds. A single undetected case in cattle can lead to a multi-million-dollar eradication effort, as seen in the 2016 Florida outbreak where the USDA spent $15 million to contain 133 animal cases. For the livestock industry, which generates over $200 billion annually, a re-establishment of screwworm would mean mandatory quarantines, trade restrictions, and increased treatment costs. Consumers would face higher meat prices as producers absorb losses from infested animals. Public health systems also bear costs: treating a human case requires surgical debridement, antibiotics, and wound care, with hospital stays averaging 5-7 days and costs exceeding $50,000 per case. The broader implication is that the U.S. sterile insect barrier, which costs about $20 million per year to maintain, is a cost-effective investment compared to the potential losses from an outbreak. The prediction market question thus serves as a real-time indicator of whether that investment is adequate. If human cases rise above the threshold, it signals that the barrier is failing, which would trigger policy debates about funding, border inspections, and climate adaptation strategies.
Current Status
As of early 2025, the U.S. has reported two human screwworm cases in 2024, both in travelers returning from Mexico. The USDA has ramped up surveillance at ports of entry, including deploying canine detection teams at 12 major border crossings. In January 2025, APHIS announced an emergency order requiring all livestock imported from Mexico to be inspected and treated with a prophylactic insecticide before entry. The Mexican outbreak continues, with over 10,000 animal cases reported in 2024, concentrated in the northern states. The USDA's sterile fly production facility in Panama is operating at full capacity, releasing 100 million flies per week along a 1,200-mile barrier zone. No human cases have been reported in the U.S. so far in 2025, but the risk remains elevated due to the proximity of the Mexican outbreak. The prediction market will resolve based on cases reported by January 8, 2027, covering all of 2026.
Frequently Asked Questions
What are the symptoms of screwworm infestation in humans?
Symptoms include a painful, enlarging wound with a foul odor, visible maggots, and sometimes fever or secondary bacterial infection. The infestation typically occurs at a pre-existing wound or mucous membrane, and the larvae feed on living tissue, causing necrosis.
Educational content is AI-generated and sourced from Wikipedia. It should not be considered financial advice.
